Technical Analysis for KHTRF - Knight Therapeutics

Grade Last Price % Change Price Change
grade C 5.1 -4.67% -0.2500
KHTRF closed down 4.67 percent on Wednesday, July 1, 2020, on 3 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Down
Historical KHTRF trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Gapped Down Weakness 0.00%
Fell Below 20 DMA Bearish -4.67%
Narrow Range Bar Range Contraction -4.67%
Gapped Down Weakness -4.67%
Crossed Above 20 DMA Bullish -5.20%
Narrow Range Bar Range Contraction -5.20%
Gapped Up Strength -5.20%
Crossed Above 50 DMA Bullish -1.47%
Expansion Pivot Buy Setup Bullish Swing Setup -1.47%
Older signals for KHTRF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Knight Therapeutics Inc. operates as a specialty pharmaceutical company in Canada and internationally. The company is involved in developing, acquiring, in-licensing, out-licensing, marketing, and distributing pharmaceutical products, consumer health products, and medical devices. Its commercialized products include Movantik to treat opioid induced constipation; Impavido, an alkyllysophospholipid analogue drug for visceral and cutaneous Leishmaniasis; Neuragen to treat pain associated with diabetic and peripheral neuropathy; Synergy family consumer health products; and Flat Tummy Tea, a herbal detox tea. The company also develops Probuphine to treat opioid addiction; NeurAxon family for acute migraine, pain, and neurological disorders; Antibe family to treat chronic pain and inflammation; AzaSite for bacterial conjunctivitis; Iluvien to treat diabetic macular edema; Netildex for ocular inflammation; 60P family to treat tropical diseases; Advaxis family to treat HPV-associated cancers and others; PHOTOFRIN for oesophageal and endobronchial cancer, high-grade dysplasia in Barrett's oesophagus, and papillary bladder cancer; ATryn to prevent thromboembolic events; Ember family to treat osteoarthritis, chronic kidney diseases, alport syndrome, and metabolic diseases; and blood factor products. In addition, it develops FLEXISEQ for pain and joint stiffness associated with osteoarthritis; dermo-cosmetic line of products, such as Crescita family, Laboratoire Dr. Renaud, Premiology, and Pro-Derm; SEQuaderma, an active dermatology solution; HandMD skin care products; and UrgentRx, a fast-acting, portable over-the-counter medication. Further, the company develops TULSA-PRO, a medical device for prostate ablation; and 3D family diagnostic and prognostic products for cancers and neurological disorders. Additionally, it finances other life science companies; and invests in life sciences venture capital funds. The company is headquartered in Montreal, Canada.
Medicine Health Medical Specialties RTT Pharmaceutical Pain Pharmaceutical Products Cancers Skin Care Products Inflammation Arthritis Metabolic Diseases Osteoarthritis Pain Management Chronic Pain Neurological Disorders Constipation Aging Associated Diseases Opioid Peripheral Neuropathy Chronic Kidney Diseases Diabetic Macular Edema Consumer Health Products Skeletal Disorders

Is KHTRF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 6.7156
52 Week Low 3.44
Average Volume 3,881
200-Day Moving Average 5.7597
50-Day Moving Average 5.0841
20-Day Moving Average 5.3681
10-Day Moving Average 5.2603
Average True Range 0.1623
ADX 12.55
+DI 43.9958
-DI 49.5530
Chandelier Exit (Long, 3 ATRs ) 5.1990
Chandelier Exit (Short, 3 ATRs ) 5.4169
Upper Bollinger Band 5.8101
Lower Bollinger Band 4.9261
Percent B (%b) 0.2
BandWidth 16.4677
MACD Line 0.0317
MACD Signal Line 0.0652
MACD Histogram -0.0335
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.1000
Resistance 3 (R3) 5.1000 5.1000 5.1000
Resistance 2 (R2) 5.1000 5.1000 5.1000 5.1000
Resistance 1 (R1) 5.1000 5.1000 5.1000 5.1000 5.1000
Pivot Point 5.1000 5.1000 5.1000 5.1000 5.1000
Support 1 (S1) 5.1000 5.1000 5.1000 5.1000 5.1000
Support 2 (S2) 5.1000 5.1000 5.1000 5.1000
Support 3 (S3) 5.1000 5.1000 5.1000
Support 4 (S4) 5.1000